Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
244 participants
INTERVENTIONAL
2007-11-30
2008-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Objective:
The objective of this study is to assess the health-related effects of a SMS compliance and monitoring system for optimized asthma treatment in a controlled trial setting.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy of Mobile Phone Short Message Service (SMS) Reminder and Consultation on Asthma Control
NCT02189616
Monitoring Adherence Using Mobile Technology
NCT02617420
Adolescent Controlled Text Messaging to Improve Asthma Medication Adherence in Primary Care
NCT02176694
Usage, Usability & Effect on Adherence and Clinical Outcomes of Text Message Reminders for Adolescents With Asthma
NCT01253330
Prospective Study of the Feedback From an Adherence Monitor on Asthma Control
NCT01529697
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
SMS intervention
SMS support
The intervention consisted of sequences of SMS messages sent to the intervention group, each containing 2 or 3 monitoring questions and one reminder to take the preventive medication. The SMS sequence was as follows.
1. Remember to take your preventive asthma medication (sent at 8.00 am).
2. Were you awakened during the night due to your asthma? Answer YES or NO.
3. How many times have you taken your asthma attack medication during the last 24 hours? Answer a number.
4. What was your peak flow this morning? Answer a number (optional, depending on the participant's use of a spirometer prior to the study).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
SMS support
The intervention consisted of sequences of SMS messages sent to the intervention group, each containing 2 or 3 monitoring questions and one reminder to take the preventive medication. The SMS sequence was as follows.
1. Remember to take your preventive asthma medication (sent at 8.00 am).
2. Were you awakened during the night due to your asthma? Answer YES or NO.
3. How many times have you taken your asthma attack medication during the last 24 hours? Answer a number.
4. What was your peak flow this morning? Answer a number (optional, depending on the participant's use of a spirometer prior to the study).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* COPD patients
* no mobile phone
* not using the prescribed asthma inhalation medication
18 Years
45 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
MedicoMonitor Aps
UNKNOWN
The Ministry of Health and Prevention, Denmark
OTHER_GOV
University of Copenhagen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
University of Copenhagen
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Claus Møldrup, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Copenhagen
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Copenhagen
Copenhagen, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UC-SMS-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.